3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
CNS
1
Conditions
Sleep Initiation and Maintenance Disorders
19
Breast Neoplasms
14
Neoplasms
12
Anxiety Disorders
7
Prostatic Neoplasms
6
Depression
5
Motor Activity
3
Lymphoma
3
Weight Loss
2
Pain
2
Overweight
2
Ovarian Neoplasms
2
Obesity
2
Multiple Myeloma
2
Lung Neoplasms
2
Glioblastoma
2
Fatigue
2
Colorectal Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Smoking
1
Small Cell Lung Carcinoma
1
Sleep Wake Disorders
1
Sexual Dysfunctions, Psychological
1
Sexual Dysfunction, Physiological
1
Sedentary Behavior
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Interventions
Temozolomide
45
Radiotherapy
16
Carboplatin
15
Irinotecan
12
Carmustine
12
Bevacizumab
12
Filgrastim
10
Vincristine
9
Surgical Procedures, Operative
9
Magnetic Resonance Spectroscopy
9
Procarbazine
7
Peripheral Blood Stem Cell Transplantation
6
Imatinib Mesylate
6
Erlotinib Hydrochloride
6
temsirolimus
5
sargramostim
5
O(6)-benzylguanine
5
Lomustine
5
Flucytosine
5
Etoposide
5
Thiotepa
4
Sirolimus
4
Cyclophosphamide
4
aldesleukin
3
Thalidomide
3
Surveys and Questionnaires
3
Sunitinib
3
Radiotherapy, Intensity-Modulated
3
Radiation
3
Polymerase Chain Reaction
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Oligodendroglioma
×
Cognitive Behavioral Therapy
×
Clear all
NCT06439420
2025-10-01
CBT-I in PBT
Virginia Commonwealth University
Phase 2
Completed
70 enrolled